BeOne Medicines ONC
NASDAQ ONC
$369.06 -5.02 (-1.34%)
At close: Oct 16, 2026 · 4:00 PM EDT

BeOne Medicines (ONC) EV to EBITDA (2025 - 2026)

Updated

BeOne Medicines' EV to EBITDA came in at 25.15 for Q2 2026, down 90.6% from 267.09 a year earlier and down 25.5% from the prior quarter.

Analysis

BeOne Medicines (ONC) EV to EBITDA (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, BeOne Medicines reported EV to EBITDA of 12.74, down 92.9% year-over-year; for FY2025, it came in at 49.47.

  • Business Quant data shows ONC's EV to EBITDA at 33.74 (Q1 2026), 49.47 (Q4 2025) and 99.38 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn
10 BeOne Medicines 41.22 Bn 22.75 Bn 1.53 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.15
Mar 31, 2026 33.74
Dec 31, 2025 49.47
Sep 30, 2025 99.38
Jun 30, 2025 267.09
API Access

BeOne Medicines EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ONC&period=max&api_key=YOUR_API_KEY